Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99 | 1,808 | 4,357 | -372 | -3,887 |
| Depreciation Amortization | 199 | 154 | 107 | 57 | 236 |
| Income taxes - deferred | -52 | N/A | N/A | N/A | N/A |
| Other Working Capital | -545 | -332 | -326 | -316 | 102 |
| Other Operating Activity | -5,515 | -5,887 | -7,256 | -1,149 | -137 |
| Operating Cash Flow | $-6,012 | $-4,257 | $-3,118 | $-1,780 | $-3,686 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -4 | N/A | N/A | -4 |
| Net Acquisitions | 783 | 589 | 589 | 589 | N/A |
| Sale Of Investment | 7,900 | 5,400 | 5,400 | N/A | N/A |
| Other Investing Activity | -2,596 | -2,621 | -2,638 | -13 | 0 |
| Investing Cash Flow | $6,082 | $3,364 | $3,351 | $576 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,866 | 2,865 | 2,807 | 2,769 | 7 |
| Financing Cash Flow | $2,866 | $2,865 | $2,807 | $2,769 | $7 |
| Beginning Cash Position | 1,034 | 1,034 | 1,034 | 1,034 | 4,717 |
| End Cash Position | 3,970 | 3,006 | 4,074 | 2,599 | 1,034 |
| Net Cash Flow | $2,936 | $1,972 | $3,040 | $1,565 | $-3,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,012 | -4,257 | -3,118 | -1,780 | -3,686 |
| Capital Expenditure | -5 | -4 | N/A | N/A | -4 |
| Free Cash Flow | -6,017 | -4,261 | -3,118 | -1,780 | -3,690 |